Tfh/Tfr Ratio in IgA Nephropathy Patients
Interest of Follicular Helper Lymphocytes / Regulatory Follicular Helper Lymphocytes Ratio in IgA Nephropathy
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 75 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Other
This trial is looking for patients with IgA nephropathy to understand how certain immune cells relate to disease progression. Participants will be grouped based on their condition and monitored over time to see how it changes.
You may be able to join if
- I have been diagnosed with IgA nephropathy confirmed by a kidney biopsy
- I have had my kidney condition for at least 5 years
- I was diagnosed from 2009 onwards
- I am part of a control group with lupus, ANCA-associated vasculitis, or polycystic kidney disease
- I have at least 8 functional glomeruli
You may not be able to join if
- I have legal incapacity or limited legal capacity
- I have no social security coverage
- I am pregnant or not using an effective contraceptive method
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThis study aims to investigate the relevance of the Tfh/Tfr (Follicular helper T cells/ Follicular regulatory T cells) ratio in patients with IgA nephropathy: * To identify a differential expression of the Tfh/Tfr ratio in patients considered stable or progressive * To predict, at diagnosis, the clinical evolution of the disease (progressive or stable form) in the first year.
Loading trial locations…